The role of omega-3 polyunsaturated fatty acids eicosapentaenoic and docosahexaenoic acids in the treatment of major depression and Alzheimer's disease: Acting separately or synergistically?

Progress in Lipid Research

Volumn 62, Issue , 2016, Pages 41-54

  Song, Cai ^a,b,c   Shieh, Chu Hsin ^b   Wu, Yi Shyuan ^b   Kalueff, Allan ^a,d,e   Gaikwad, Siddharth ^b   Su, Kuan Pin ^b  

^a GUANGDONG OCEAN UNIVERSITY   (China)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c DALHOUSIE UNIVERSITY   (Canada)

^d URAL FEDERAL UNIVERSITY   (Russian Federation)

^e ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

Author keywords

Alzheimer's disease; Docosahexaenoic acid; Eicosapentaenoic acid; Inflammation; Major depressive disorder; Neurogenesis

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; PLACEBO; ANTIINFLAMMATORY AGENT; ANTIOXIDANT;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; FATTY ACID SYNTHESIS; HUMAN; MAJOR DEPRESSION; MONOTHERAPY; NEUROMODULATION; NEUROTROPISM; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TRANSLATIONAL RESEARCH; ANIMAL; DIET THERAPY; DRUG EFFECTS; GENETICS; METABOLISM; NERVOUS SYSTEM DEVELOPMENT; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; DEPRESSIVE DISORDER, MAJOR; DOCOSAHEXAENOIC ACIDS; DRUG SYNERGISM; EICOSAPENTAENOIC ACID; HUMANS; NEUROGENESIS; SIGNAL TRANSDUCTION;

EID: 84955317668     PISSN: 01637827     EISSN: 18732194     Source Type: Journal    
DOI: 10.1016/j.plipres.2015.12.003     Document Type: Review

References (192)

1. D.J. Kupfer, E. Frank, and M.L. Phillips Major depressive disorder: new clinical, neurobiological, and treatment perspectives Lancet 379 2012 1045 1055
2. L. Soleimani, K.A. Lapidus, and D.V. Iosifescu Diagnosis and treatment of major depressive disorder Neurol. Clin. 29 2011 177 193 ix
3. B.E. Leonard Inflammation, depression and dementia: are they connected? Neurochem. Res. 32 2007 1749 1756
4. C. Anacker, A. Cattaneo, A. Luoni, K. Musaelyan, P.A. Zunszain, E. Milanesi, and et al. Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis Neuropsychopharmacology 38 2013 872 883
5. R. Schliebs, and T. Arendt The cholinergic system in aging and neuronal degeneration Behav. Brain Res. 221 2011 555 563
6. Y.W. Zhang, R. Thompson, H. Zhang, and H. Xu APP processing in Alzheimer's disease Mol. Brain 4 2011 3
7. S. Alesci, P.E. Martinez, S. Kelkar, I. Ilias, D.S. Ronsaville, S.J. Listwak, and et al. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications J. Clin. Endocrinol. Metab. 90 2005 2522 2530
8. S.K. Lutgendorf, L. Garand, K.C. Buckwalter, T.T. Reimer, S.Y. Hong, and D.M. Lubaroff Life stress, mood disturbance, and elevated interleukin-6 in healthy older women J. Gerontol. A Biol. Sci. Med. Sci. 54 1999 M434 M439
9. R. Mota, M. Gazal, B.A. Acosta, P.B. de Leon, K. Jansen, R.T. Pinheiro, and et al. Interleukin-1beta is associated with depressive episode in major depression but not in bipolar disorder J. Psychiatr. Res. 47 2013 2011 2014
10. R. Dantzer Cytokine-induced sickness behavior: where do we stand? Brain Behav. Immun. 15 2001 7 24
11. R. Dantzer Cytokine, sickness behavior, and depression Immunol. Allergy Clin. N. Am. 29 2009 247 264
12. J. Steiner, T. Gos, B. Bogerts, H. Bielau, H.A. Drexhage, and H.G. Bernstein Possible impact of microglial cells and the monocyte-macrophage system on suicidal behavior CNS Neurol. Disord. Drug Targets 12 2013 971 979
13. J. Steiner, M. Walter, T. Gos, G.J. Guillemin, H.G. Bernstein, Z. Sarnyai, and et al. Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? J. Neuroinflammation 8 2011 94
14. G.Z. Reus, G.R. Fries, L. Stertz, M. Badawy, I.C. Passos, T. Barichello, and et al. The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders Neuroscience 300 2015 141 154
15. S. Sarkar, R. Sarkar, T. Berg, and M. Schaefer Sadness and mild cognitive impairment as predictors for interferon-alpha-induced depression in patients with hepatitis C Br. J. Psychiatry 206 2015 45 51
16. J. Vignau, L. Karila, O. Costisella, and V. Canva Hepatitis C, interferon a and depression: main physiopathologic hypothesis Encéphale 31 2005 349 357
17. S. Biesmans, T.F. Meert, J.A. Bouwknecht, P.D. Acton, N. Davoodi, P. De Haes, and et al. Systemic immune activation leads to neuroinflammation and sickness behavior in mice Mediat. Inflamm. 2013 2013 271359
18. C.J. Henry, Y. Huang, A. Wynne, M. Hanke, J. Himler, M.T. Bailey, and et al. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia J. Neuroinflammation 5 2008 15
19. J. Hannestad, N. DellaGioia, and M. Bloch The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis Neuropsychopharmacology 36 2011 2452 2459
20. M. Ehret, and D.M. Sobieraj Prevention of interferon-alpha-associated depression with antidepressant medications in patients with hepatitis C virus: a systematic review and meta-analysis Int. J. Clin. Pract. 68 2014 255 261
21. L. Qin, Y. Liu, C. Cooper, B. Liu, B. Wilson, and J.S. Hong Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species J. Neurochem. 83 2002 973 983
22. H.J. Tsay, Y.C. Huang, F.L. Huang, C.P. Chen, Y.C. Tsai, Y.H. Wang, and et al. Amyloid beta peptide-mediated neurotoxicity is attenuated by the proliferating microglia more potently than by the quiescent phenotype J. Biomed. Sci. 20 2013 78
23. D. Zhang, X. Hu, L. Qian, S.H. Chen, H. Zhou, B. Wilson, and et al. Microglial MAC1 receptor and PI3K are essential in mediating beta-amyloid peptide-induced microglial activation and subsequent neurotoxicity J. Neuroinflammation 8 2011 3
24. D. Baglietto-Vargas, R. Medeiros, H. Martinez-Coria, F.M. LaFerla, and K.N. Green Mifepristone alters amyloid precursor protein processing to preclude amyloid beta and also reduces tau pathology Biol. Psychiatry 74 2013 357 366
25. M.P. Austin, P. Mitchell, and G.M. Goodwin Cognitive deficits in depression: possible implications for functional neuropathology Br. J. Psychiatry 178 2001 200 206
26. C.G. Lyketsos, and J. Olin Depression in Alzheimer's disease: overview and treatment Biol. Psychiatry 52 2002 243 252
27. F. Licastro, S. Pedrini, L. Caputo, G. Annoni, L.J. Davis, C. Ferri, and et al. Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain? J. Neuroimmunol. 103 2000 97 102
28. J.A. Nicoll, R.E. Mrak, D.I. Graham, J. Stewart, G. Wilcock, S. MacGowan, and et al. Association of interleukin-1 gene polymorphisms with Alzheimer's disease Ann. Neurol. 47 2000 365 368
29. C. Song, Y. Zhang, and Y. Dong Acute and subacute IL-1beta administrations differentially modulate neuroimmune and neurotrophic systems: possible implications for neuroprotection and neurodegeneration J. Neuroinflammation 10 2013 59
30. C. Song, D.F. Horrobin, and B.E. Leonard The comparison of changes in behavior, neurochemistry, endocrine, and immune functions after different routes, doses and durations of administrations of IL-1beta in rats Pharmacopsychiatry 39 2006 88 99
31. G.J. Guillemin, S.J. Kerr, G.A. Smythe, D.G. Smith, V. Kapoor, P.J. Armati, and et al. Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection J. Neurochem. 78 2001 842 853
32. O. Takikawa Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolism Biochem. Biophys. Res. Commun. 338 2005 12 19
33. J.P. Kim, and D.W. Choi Quinolinate neurotoxicity in cortical cell culture Neuroscience 23 1987 423 432
34. E.J. Huang, and L.F. Reichardt Neurotrophins: roles in neuronal development and function Annu. Rev. Neurosci. 24 2001 677 736
35. K. Bartkowska, A. Paquin, A.S. Gauthier, D.R. Kaplan, and F.D. Miller Trk signaling regulates neural precursor cell proliferation and differentiation during cortical development Development 134 2007 4369 4380
36. Y. Li, B.W. Luikart, S. Birnbaum, J. Chen, C.H. Kwon, S.G. Kernie, and et al. TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment Neuron 59 2008 399 412
37. H. Koshimizu, S. Hazama, T. Hara, A. Ogura, and M. Kojima Distinct signaling pathways of precursor BDNF and mature BDNF in cultured cerebellar granule neurons Neurosci. Lett. 473 2010 229 232
38. H.K. Teng, K.K. Teng, R. Lee, S. Wright, S. Tevar, R.D. Almeida, and et al. ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin J. Neurosci. 25 2005 5455 5463
39. B.A. Bus, M.L. Molendijk, I. Tendolkar, B.W. Penninx, J. Prickaerts, B.M. Elzinga, and et al. Chronic depression is associated with a pronounced decrease in serum brain-derived neurotrophic factor over time Mol. Psychiatry 20 2015 602 608
40. Y.M. Park, B.H. Lee, T.H. Um, and S. Kim Serum BDNF levels in relation to illness severity, suicide attempts, and central serotonin activity in patients with major depressive disorder: a pilot study PLoS ONE 9 2014 e91061
41. C. Hock, K. Heese, C. Hulette, C. Rosenberg, and U. Otten Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas Arch. Neurol. 57 2000 846 851
42. H.S. Phillips, J.M. Hains, M. Armanini, G.R. Laramee, S.A. Johnson, and J.W. Winslow BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease Neuron 7 1991 695 702
43. F. Matrisciano, S. Bonaccorso, A. Ricciardi, S. Scaccianoce, I. Panaccione, L. Wang, and et al. Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine J. Psychiatr. Res. 43 2009 247 254
44. O.M. Wolkowitz, J. Wolf, W. Shelly, R. Rosser, H.M. Burke, G.K. Lerner, and et al. Serum BDNF levels before treatment predict SSRI response in depression Prog. Neuro-Psychopharmacol. Biol. Psychiatry 35 2011 1623 1630
45. M. Prior, R. Dargusch, J.L. Ehren, C. Chiruta, and D. Schubert The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease mice Alzheimers Res. Ther. 5 2013 25
46. S. Riemer, M. Maes, A. Christophe, and W. Rief Lowered omega-3 PUFAs are related to major depression, but not to somatization syndrome J. Affect. Disord. 123 2010 173 180
47. J.A. Conquer, M.C. Tierney, J. Zecevic, W.J. Bettger, and R.H. Fisher Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment Lipids 35 2000 1305 1312
48. S. Tsuchimine, M. Saito, S. Kaneko, and N. Yasui-Furukori Decreased serum levels of polyunsaturated fatty acids and folate, but not brain-derived neurotrophic factor, in childhood and adolescent females with depression Psychiatry Res. 225 2015 187 190
49. S.M. Conklin, S.B. Manuck, J.K. Yao, J.D. Flory, J.R. Hibbeln, and M.F. Muldoon High omega-6 and low omega-3 fatty acids are associated with depressive symptoms and neuroticism Psychosom. Med. 69 2007 932 934
50. P.B. Adams, S. Lawson, A. Sanigorski, and A.J. Sinclair Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression Lipids 31 Suppl 1996 S157 S161
51. C.C. Chiu, S. Frangou, C.J. Chang, W.C. Chiu, H.C. Liu, I.W. Sun, and et al. Associations between n - 3 PUFA concentrations and cognitive function after recovery from late-life depression Am. J. Clin. Nutr. 95 2012 420 427
52. Z.S. Tan, W.S. Harris, A.S. Beiser, R. Au, J.J. Himali, S. Debette, and et al. Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging Neurology 78 2012 658 664
53. C. Samieri, C. Feart, C. Proust-Lima, E. Peuchant, J.F. Dartigues, H. Amieva, and et al. Omega-3 fatty acids and cognitive decline: modulation by ApoEepsilon4 allele and depression Neurobiol. Aging 32 2317 2011 e13 e22
54. W. Stonehouse Does consumption of LC omega-3 PUFA enhance cognitive performance in healthy school-aged children and throughout adulthood? Evidence from clinical trials Nutrients. 6 2014 2730 2758
55. A.V. Witte, L. Kerti, H.M. Hermannstadter, J.B. Fiebach, S.J. Schreiber, J.P. Schuchardt, and et al. Long-chain omega-3 fatty acids improve brain function and structure in older adults Cereb. Cortex 24 2014 3059 3068
56. S.M. Conklin, P.J. Gianaros, S.M. Brown, J.K. Yao, A.R. Hariri, S.B. Manuck, and et al. Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults Neurosci. Lett. 421 2007 209 212
57. G. Barceló-Coblijn, and M. EJ. Alpha-linolenic acid and its conversion to longer chain n - 3 fatty acids: benefits for human health and a role in maintaining tissue n - 3 fatty acid levels Prog. Lipid Res. 48 2009 74 355
58. G.C. Burdge, and S.A. Wootton Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women Br. J. Nutr. 88 2002 411 420
59. R.J. Pawlosky, J.R. Hibbeln, J.A. Novotny, and N. Salem Jr. Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans J. Lipid Res. 42 2001 1257 1265
60. R.H. de Groot, G. Hornstra, A.C. van Houwelingen, and F. Roumen Effect of alpha-linolenic acid supplementation during pregnancy on maternal and neonatal polyunsaturated fatty acid status and pregnancy outcome Am. J. Clin. Nutr. 79 2004 251 260
61. Z. Fu, and A.J. Sinclair Increased alpha-linolenic acid intake increases tissue alpha-linolenic acid content and apparent oxidation with little effect on tissue docosahexaenoic acid in the guinea pig Lipids 35 2000 395 400
62. H. Sprecher Metabolism of highly unsaturated n - 3 and n - 6 fatty acids Biochim. Biophys. Acta 1486 2000 219 231
63. M.K. Gregory, R.A. Gibson, R.J. Cook-Johnson, L.G. Cleland, and M.J. James Elongase reactions as control points in long-chain polyunsaturated fatty acid synthesis PLoS ONE 6 2011 e29662
64. M.K. Gregory, and M.J. James Functional characterization of the duck and turkey fatty acyl elongase enzymes ELOVL5 and ELOVL2 J. Nutr. 144 2014 1234 1239
65. S.C. Cunnane, V. Francescutti, J.T. Brenna, and M.A. Crawford Breast-fed infants achieve a higher rate of brain and whole body docosahexaenoate accumulation than formula-fed infants not consuming dietary docosahexaenoate Lipids 35 2000 105 111
66. G. Zhu, X. Jiang, Q. Ou, T. Zhang, M. Wang, G. Sun, and et al. Enhanced production of docosahexaenoic acid in mammalian cells PLoS ONE 9 2014 e96503
67. Y. Wang, A.V. Botelho, G.V. Martinez, and M.F. Brown Electrostatic properties of membrane lipids coupled to metarhodopsin II formation in visual transduction J. Am. Chem. Soc. 124 2002 7690 7701
68. M.O. Grimm, V.C. Zimmer, J. Lehmann, H.S. Grimm, and T. Hartmann The impact of cholesterol, DHA, and sphingolipids on Alzheimer's disease Biomed. Res. Int. 2013 2013 814390
69. S.R. Wassall, and W. Stillwell Polyunsaturated fatty acid-cholesterol interactions: domain formation in membranes Biochim. Biophys. Acta 2009 1788 24 32
70. M. Hashimoto, S. Hossain, and O. Shido Docosahexaenoic acid but not eicosapentaenoic acid withstands dietary cholesterol-induced decreases in platelet membrane fluidity Mol. Cell. Biochem. 293 2006 1 8
71. M. Hashimoto, S. Hossain, H. Yamasaki, K. Yazawa, and S. Masumura Effects of eicosapentaenoic acid and docosahexaenoic acid on plasma membrane fluidity of aortic endothelial cells Lipids 34 1999 1297 1304
72. M. Treen, R.D. Uauy, D.M. Jameson, V.L. Thomas, and D.R. Hoffman Effect of docosahexaenoic acid on membrane fluidity and function in intact cultured Y-79 retinoblastoma cells Arch. Biochem. Biophys. 294 1992 564 570
73. M. Cansev, R.J. Wurtman, T. Sakamoto, and I.H. Ulus Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses Alzheimers Dement. 4 2008 S153 S168
74. M. Chessin, E.R. Kramer, and C.C. Scott Modifications of the pharmacology of reserpine and serotonin by iproniazid J. Pharmacol. Exp. Ther. 119 1957 453 460
75. R. Mercier, P. Dominguez-Cuevas, and J. Errington Crucial role for membrane fluidity in proliferation of primitive cells Cell Rep. 1 2012 417 423
76. D. Cao, K. Kevala, J. Kim, H.S. Moon, S.B. Jun, D. Lovinger, and et al. Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function J. Neurochem. 111 2009 510 521
77. B.G. Jeffrey, H.S. Weisinger, M. Neuringer, and D.C. Mitchell The role of docosahexaenoic acid in retinal function Lipids 36 2001 859 871
78. C.L. Jensen, R.G. Voigt, T.C. Prager, Y.L. Zou, J.K. Fraley, J.C. Rozelle, and et al. Effects of maternal docosahexaenoic acid intake on visual function and neurodevelopment in breastfed term infants Am. J. Clin. Nutr. 82 2005 125 132
79. R.J. Wurtman, M. Cansev, and I.H. Ulus Synapse formation is enhanced by oral administration of uridine and DHA, the circulating precursors of brain phosphatides J. Nutr. Health Aging 13 2009 189 197
80. A. Kawashima, T. Harada, H. Kami, T. Yano, K. Imada, and K. Mizuguchi Effects of eicosapentaenoic acid on synaptic plasticity, fatty acid profile and phosphoinositide 3-kinase signaling in rat hippocampus and differentiated PC12 cells J. Nutr. Biochem. 21 2010 268 277
81. S. Salvati, F. Natali, L. Attorri, R. Di Benedetto, F. Leonardi, A. Di Biase, and et al. Eicosapentaenoic acid stimulates the expression of myelin proteins in rat brain J. Neurosci. Res. 86 2008 776 784
82. Y.V. Wee Inflammation in neurological disorders: a help or a hindrance? Neuroscientist 16 2010 408 420
83. A. Czlonkowska, and I. Kurkowska-Jastrzebska Inflammation and gliosis in neurological diseases - clinical implications J. Neuroimmunol. 231 2011 78 85
84. D. Nieves, and J.J. Moreno Effect of arachidonic and eicosapentaenoic acid metabolism on RAW 264.7 macrophage proliferation J. Cell. Physiol. 208 2006 428 434
85. T.G. Brock, and M. Peters-Golden Activation and regulation of cellular eicosanoid biosynthesis ScientificWorldJournal 7 2007 1273 1284
86. H. Harizi, J.B. Corcuff, and N. Gualde Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology Trends Mol. Med. 14 2008 461 469
87. P.C. Calder Long-chain n - 3 fatty acids and inflammation: potential application in surgical and trauma patients Braz. J. Med. Biol. Res. 36 2003 433 446
88. T. Babcock, W.S. Helton, and N.J. Espat Eicosapentaenoic acid (EPA): an antiinflammatory omega-3 fat with potential clinical applications Nutrition 16 2000 1116 1118
89. O. Adam, C. Beringer, T. Kless, C. Lemmen, A. Adam, M. Wiseman, and et al. Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis Rheumatol. Int. 23 2003 27 36
90. H. Ohnishi, and Y. Saito Eicosapentaenoic acid (EPA) reduces cardiovascular events: relationship with the EPA/arachidonic acid ratio J. Atheroscler. Thromb. 20 2013 861 877
91. Y. Jiang, Z. Djuric, A. Sen, J. Ren, D. Kuklev, I. Waters, and et al. Biomarkers for personalizing omega-3 fatty acid dosing Cancer Prev. Res. (Phila.) 7 2014 1011 1022
92. C. Song, X. Li, B.E. Leonard, and D.F. Horrobin Effects of dietary n - 3 or n - 6 fatty acids on interleukin-1beta-induced anxiety, stress, and inflammatory responses in rats J. Lipid Res. 44 2003 1984 1991
93. C. Song, X.Y. Zhang, and M. Manku Increased phospholipase A2 activity and inflammatory response but decreased nerve growth factor expression in the olfactory bulbectomized rat model of depression: effects of chronic ethyl-eicosapentaenoate treatment J. Neurosci. 29 2009 14 22
94. 2 formation and impact in inflammation resolution J. Immunol. 188 2012 4527 4534
95. C.N. Serhan, M. Arita, S. Hong, and K. Gotlinger Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers Lipids 39 2004 1125 1132
96. P. Cotogni, G. Muzio, A. Trombetta, V.M. Ranieri, and R.A. Canuto Impact of the omega-3 to omega-6 polyunsaturated fatty acid ratio on cytokine release in human alveolar cells JPEN J. Parenter. Enteral Nutr. 35 2011 114 121
97. L. Li, Y. Wu, Y. Wang, J. Wu, L. Song, W. Xian, and et al. Resolvin D1 promotes the interleukin-4-induced alternative activation in BV-2 microglial cells J. Neuroinflammation 11 2014 72
98. C.N. Serhan, G. Fredman, R. Yang, S. Karamnov, L.S. Belayev, N.G. Bazan, and et al. Novel proresolving aspirin-triggered DHA pathway Chem. Biol. 18 2011 976 987
99. R.L. Castillo, C. Arias, and J.G. Farias Omega 3 chronic supplementation attenuates myocardial ischaemia-reperfusion injury through reinforcement of antioxidant defense system in rats Cell Biochem. Funct. 32 2014 274 281
100. B. Guermouche, N.A. Soulimane-Mokhtari, S. Bouanane, H. Merzouk, S. Merzouk, and M. Narce Effect of dietary n - 3 polyunsaturated fatty acids on oxidant/antioxidant status in macrosomic offspring of diabetic rats Biomed. Res. Int. 2014 2014 368107
101. L. Lluis, N. Taltavull, M. Munoz-Cortes, V. Sanchez-Martos, M. Romeu, M. Giralt, and et al. Protective effect of the omega-3 polyunsaturated fatty acids: eicosapentaenoic acid/docosahexaenoic acid 1:1 ratio on cardiovascular disease risk markers in rats Lipids Health Dis. 12 2013 140
102. M.M. Roca-Rodriguez, J.M. Garcia-Almeida, Y. Lupianez-Perez, J.M. Rico, M. Toledo, J. Alcaide-Torres, and et al. Effect of a specific supplement enriched with n - 3 polyunsaturated fatty acids on markers of inflammation, oxidative stress and metabolic status of ear, nose and throat cancer patients Oncol. Rep. 31 2014 405 414
103. J. Ruszkiewicz, and A. J. Changes in the mitochondrial antioxidant systems in neurodegenerative diseases and acute brain disorders Neurochem Int. 88 2015 66 72
104. L. Corsi, B.M. Dongmo, and R. Avallone Supplementation of omega 3 fatty acids improves oxidative stress in activated BV2 microglial cell line Int. J. Food Sci. Nutr. 66 2015 293 299
105. Q. Liu, D. Wu, N. Ni, H. Ren, C. Luo, C. He, and et al. Omega-3 polyunsaturated fatty acids protect neural progenitor cells against oxidative injury Mar. Drugs 12 2014 2341 2356
106. T. Koumura, C. Nakamura, and Y. Nakagawa Involvement of hydroperoxide in mitochondria in the induction of apoptosis by the eicosapentaenoic acid Free Radic. Res. 39 2005 225 235
107. V.A. Paschoal, M.A. Vinolo, A.R. Crisma, J. Magdalon, and R. Curi Eicosapentaenoic (EPA) and docosahexaenoic (DHA) acid differentially modulate rat neutrophil function in vitro Lipids 48 2013 93 103
108. D. Mischoulon, G.I. Papakostas, C.M. Dording, A.H. Farabaugh, S.B. Sonawalla, A.M. Agoston, and et al. A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder J. Clin. Psychiatry 70 2009 1636 1644
109. M. Peet, and D.F. Horrobin A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs Arch. Gen. Psychiatry 59 2002 913 919
110. S. Frangou, M. Lewis, and P. McCrone Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study Br. J. Psychiatry 188 2006 46 50
111. K.P. Su, H.C. Lai, H.T. Yang, W.P. Su, C.Y. Peng, J.P. Chang, and et al. Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized, controlled trial Biol. Psychiatry 76 2014 559 566
112. L.B. Marangell, J.M. Martinez, H.A. Zboyan, B. Kertz, H.F. Kim, and L.J. Puryear A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression Am. J. Psychiatry 160 2003 996 998
113. H. Mozaffari-Khosravi, M. Yassini-Ardakani, M. Karamati, and S.E. Shariati-Bafghi Eicosapentaenoic acid versus docosahexaenoic acid in mild-to-moderate depression: a randomized, double-blind, placebo-controlled trial Eur. Neuropsychopharmacol. 23 2013 636 644
114. H. Nemets, B. Nemets, A. Apter, Z. Bracha, and R.H. Belmaker Omega-3 treatment of childhood depression: a controlled, double-blind pilot study Am. J. Psychiatry 163 2006 1098 1100
115. K.P. Su, S.Y. Huang, C.C. Chiu, and W.W. Shen Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial Eur. Neuropsychopharmacol. 13 2003 267 271
116. K. Krawczyk, and R. J Augmentation of antidepressants with unsaturated fatty acids omega-3 in drug-resistant depression Psychiatr. Pol. 46 2012 585 598
117. P.J. Rogers, K.M. Appleton, D. Kessler, T.J. Peters, D. Gunnell, R.C. Hayward, and et al. No effect of n - 3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial Br. J. Nutr. 99 2008 421 431
118. K.M. Silvers, C.C. Woolley, F.C. Hamilton, P.M. Watts, and R.A. Watson Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression Prostaglandins Leukot. Essent. Fat. Acids 72 2005 211 218
119. B.J. Meyer, B.F. Grenyer, T. Crowe, A.J. Owen, E.M. Grigonis-Deane, and P.R. Howe Improvement of major depression is associated with increased erythrocyte DHA Lipids 48 2013 863 868
120. M.W. Markhus, S. Skotheim, I.E. Graff, L. Froyland, H.C. Braarud, K.M. Stormark, and et al. Low omega-3 index in pregnancy is a possible biological risk factor for postpartum depression PLoS ONE 8 2013 e67617
121. C.M. da Rocha, and G. Kac High dietary ratio of omega-6 to omega-3 polyunsaturated acids during pregnancy and prevalence of post-partum depression Matern. Child Nutr. 8 2012 36 48
122. K.P. Su, S.Y. Huang, T.H. Chiu, K.C. Huang, C.L. Huang, H.C. Chang, and et al. Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial J. Clin. Psychiatry 69 2008 644 651
123. A.M. Rees, M.P. Austin, and G.B. Parker Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial Aust. N. Z. J. Psychiatry 42 2008 199 205
124. M.P. Freeman, M. Davis, P. Sinha, K.L. Wisner, J.R. Hibbeln, and A.J. Gelenberg Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study J. Affect. Disord. 110 2008 142 148
125. M. Lucas, G. Asselin, C. Merette, M.J. Poulin, and S. Dodin Ethyl-eicosapentaenoic acid for the treatment of psychological distress and depressive symptoms in middle-aged women: a double-blind, placebo-controlled, randomized clinical trial Am. J. Clin. Nutr. 89 2009 641 651
126. A.M. Rizzo, P.A. Corsetto, G. Montorfano, A. Opizzi, M. Faliva, A. Giacosa, and et al. Comparison between the AA/EPA ratio in depressed and non depressed elderly females: omega-3 fatty acid supplementation correlates with improved symptoms but does not change immunological parameters Nutr. J. 11 2012 82
127. M. Rondanelli, A. Giacosa, A. Opizzi, C. Pelucchi, C. La Vecchia, G. Montorfano, and et al. Effect of omega-3 fatty acids supplementation on depressive symptoms and on health-related quality of life in the treatment of elderly women with depression: a double-blind, placebo-controlled, randomized clinical trial J. Am. Coll. Nutr. 29 2010 55 64
128. N. Sinn, C.M. Milte, S.J. Street, J.D. Buckley, A.M. Coates, J. Petkov, and et al. Effects of n - 3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial Br. J Nutr. 107 2012 1682 1693
129. S. Jazayeri, S.A. Keshavarz, M. Tehrani-Doost, M. Djalali, M. Hosseini, H. Amini, and et al. Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 concentrations in patients with major depressive disorder Psychiatry Res. 178 2010 112 115
130. L. Gertsik, R.E. Poland, C. Bresee, and M.H. Rapaport Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder J. Clin. Psychopharmacol. 32 2012 61 64
131. K. Yurko-Mauro, D. McCarthy, D. Rom, E.B. Nelson, A.S. Ryan, A. Blackwell, and et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline Alzheimers Dement. 6 2010 456 464
132. E.J. Johnson, K. McDonald, S.M. Caldarella, H.Y. Chung, A.M. Troen, and D.M. Snodderly Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women Nutr. Neurosci. 11 2008 75 83
133. J.F. Quinn, R. Raman, R.G. Thomas, K. Yurko-Mauro, E.B. Nelson, C. Van Dyck, and et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial J. Am. Med. Assoc. 304 2010 1903 1911
134. L.K. Lee, S. Shahar, A.V. Chin, and N.A. Yusoff Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial Psychopharmacology (Berlin) 225 2013 605 612
135. Y. Freund-Levi, M. Eriksdotter-Jonhagen, T. Cederholm, H. Basun, G. Faxen-Irving, A. Garlind, and et al. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial Arch. Neurol. 63 2006 1402 1408
136. D.K. Johnson, C.H. Wilkins, and J.C. Morris Accelerated weight loss may precede diagnosis in Alzheimer disease Arch. Neurol. 63 2006 1312 1317
137. H. White, C. Pieper, and K. Schmader The association of weight change in Alzheimer's disease with severity of disease and mortality: a longitudinal analysis J. Am. Geriatr. Soc. 46 1998 1223 1227
138. H. White, C. Pieper, K. Schmader, and G. Fillenbaum Weight change in Alzheimer's disease J. Am. Geriatr. Soc. 44 1996 265 272
139. G.F. Irving, Y. Freund-Levi, M. Eriksdotter-Jonhagen, H. Basun, K. Brismar, E. Hjorth, and et al. Omega-3 fatty acid supplementation effects on weight and appetite in patients with Alzheimer's disease: the omega-3 Alzheimer's disease study J. Am. Geriatr. Soc. 57 2009 11 17
140. C. Song, M.S. Manku, and D.F. Horrobin Long-chain polyunsaturated fatty acids modulate interleukin-1beta-induced changes in behavior, monoaminergic neurotransmitters, and brain inflammation in rats J. Nutr. 138 2008 954 963
141. Y. Freund Levi, I. Vedin, T. Cederholm, H. Basun, G. Faxen Irving, M. Eriksdotter, and et al. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study J. Intern. Med. 275 2014 428 436
142. I. Vedin, T. Cederholm, Y. Freund-Levi, H. Basun, A. Garlind, G.F. Irving, and et al. Effects of DHA-rich n - 3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study PLoS ONE 7 2012 e35425
143. I. Vedin, T. Cederholm, Y. Freund Levi, H. Basun, A. Garlind, G. Faxen Irving, and et al. Effects of docosahexaenoic acid-rich n - 3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study Am. J. Clin. Nutr. 87 2008 1616 1622
144. I. Vedin, T. Cederholm, Y. Freund-Levi, H. Basun, E. Hjorth, G.F. Irving, and et al. Reduced prostaglandin F2 alpha release from blood mononuclear leukocytes after oral supplementation of omega3 fatty acids: the OmegAD study J. Lipid Res. 51 2010 1179 1185
145. E. Kodas, L. Galineau, S. Bodard, S. Vancassel, D. Guilloteau, J.C. Besnard, and et al. Serotoninergic neurotransmission is affected by n - 3 polyunsaturated fatty acids in the rat J. Neurochem. 89 2004 695 702
146. L. Zimmer, S. Vancassel, S. Cantagrel, P. Breton, S. Delamanche, D. Guilloteau, and et al. The dopamine mesocorticolimbic pathway is affected by deficiency in n - 3 polyunsaturated fatty acids Am. J. Clin. Nutr. 75 2002 662 667
147. R.J. Mocking, H.G. Ruhe, J. Assies, A. Lok, M.W. Koeter, I. Visser, and et al. Relationship between the hypothalamic-pituitary-adrenal-axis and fatty acid metabolism in recurrent depression Psychoneuroendocrinology 38 2013 1607 1617
148. L.H. Jiang, Q.Y. Liang, and Y. Shi Pure docosahexaenoic acid can improve depression behaviors and affect HPA axis in mice Eur. Rev. Med. Pharmacol. Sci. 16 2012 1765 1773
149. W. Kou, D. Luchtman, and C. Song Eicosapentaenoic acid (EPA) increases cell viability and expression of neurotrophin receptors in retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cells Eur. J. Nutr. 47 2008 104 113
150. C. Song, A.G. Phillips, B.E. Leonard, and D.F. Horrobin Ethyl-eicosapentaenoic acid ingestion prevents corticosterone-mediated memory impairment induced by central administration of interleukin-1beta in rats Mol. Psychiatry 9 2004 630 638
151. B. Carabelli, A.M. Delattre, C. Pudell, M.A. Mori, D. Suchecki, R.B. Machado, and et al. The antidepressant-like effect of fish oil: possible role of ventral hippocampal 5-HT1A post-synaptic receptor Mol. Neurobiol. 52 2015 206 215
152. A. Vines, A.M. Delattre, M.M. Lima, L.S. Rodrigues, D. Suchecki, R.B. Machado, and et al. The role of 5-HT(1)A receptors in fish oil-mediated increased BDNF expression in the rat hippocampus and cortex: a possible antidepressant mechanism Neuropharmacology 62 2012 184 191
153. M. Tang, P. Jiang, H. Li, H. Cai, Y. Liu, H. Gong, and et al. Antidepressant-like effect of n - 3 PUFAs in CUMS rats: role of tPA/PAI-1 system Physiol. Behav. 139 2015 210 215
154. A. Nimmerjahn, F. Kirchhoff, and F. Helmchen Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo Science 308 2005 1314 1318
155. M.E. Tremblay, B. Stevens, A. Sierra, H. Wake, A. Bessis, and A. Nimmerjahn The role of microglia in the healthy brain J. Neurosci. 31 2011 16064 16069
156. D. Ferrari, P. Chiozzi, S. Falzoni, S. Hanau, and F. Di Virgilio Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin J. Exp. Med. 185 1997 579 582
157. S.A. Friedle, V.M. Brautigam, M. Nikodemova, M.L. Wright, and J.J. Watters The P2X7-Egr pathway regulates nucleotide-dependent inflammatory gene expression in microglia Glia 59 2011 1 13
158. I. Hide, M. Tanaka, A. Inoue, K. Nakajima, S. Kohsaka, K. Inoue, and et al. Extracellular ATP triggers tumor necrosis factor-alpha release from rat microglia J. Neurochem. 75 2000 965 972
159. S. Koizumi, Y. Shigemoto-Mogami, K. Nasu-Tada, Y. Shinozaki, K. Ohsawa, M. Tsuda, and et al. UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis Nature 446 2007 1091 1095
160. L. Li, J. Lu, S.S. Tay, S.M. Moochhala, and B.P. He The function of microglia, either neuroprotection or neurotoxicity, is determined by the equilibrium among factors released from activated microglia in vitro Brain Res. 1159 2007 8 17
161. K.M. Boje, and P.K. Arora Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death Brain Res. 587 1992 250 256
162. Y.S. Kim, and T.H. Joh Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease Exp. Mol. Med. 38 2006 333 347
163. G. Krabbe, A. Halle, V. Matyash, J.L. Rinnenthal, G.D. Eom, U. Bernhardt, and et al. Functional impairment of microglia coincides with beta-amyloid deposition in mice with Alzheimer-like pathology PLoS ONE 8 2013 e60921
164. E. Hjorth, M. Zhu, V.C. Toro, I. Vedin, J. Palmblad, T. Cederholm, and et al. Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-beta42 by human microglia and decrease inflammatory markers J. Alzheimers Dis. 35 2013 697 713
165. A.M. Lynch, D.J. Loane, A.M. Minogue, R.M. Clarke, D. Kilroy, R.E. Nally, and et al. Eicosapentaenoic acid confers neuroprotection in the amyloid-beta challenged aged hippocampus Neurobiol. Aging 28 2007 845 855
166. S. Serini, A. Bizzarro, E. Piccioni, E. Fasano, C. Rossi, A. Lauria, and et al. EPA and DHA differentially affect in vitro inflammatory cytokine release by peripheral blood mononuclear cells from Alzheimer's patients Curr. Alzheimer Res. 9 2012 913 923
167. C. Song, and D. Horrobin Omega-3 fatty acid ethyl-eicosapentaenoate, but not soybean oil, attenuates memory impairment induced by central IL-1beta administration J. Lipid Res. 45 2004 1112 1121
168. P. Taepavarapruk, and C. Song Reductions of acetylcholine release and nerve growth factor expression are correlated with memory impairment induced by interleukin-1beta administrations: effects of omega-3 fatty acid EPA treatment J. Neurochem. 112 2010 1054 1064
169. A.M. Minogue, A.M. Lynch, D.J. Loane, C.E. Herron, and M.A. Lynch Modulation of amyloid-beta-induced and age-associated changes in rat hippocampus by eicosapentaenoic acid J. Neurochem. 103 2007 914 926
170. Y. Zhao, F. Calon, C. Julien, J.W. Winkler, N.A. Petasis, W.J. Lukiw, and et al. Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARgamma-mediated mechanisms in Alzheimer's disease models PLoS ONE 6 2011 e15816
171. M. Torres, S.L. Price, M.A. Fiol-Deroque, A. Marcilla-Etxenike, H. Ahyayauch, G. Barcelo-Coblijn, and et al. Membrane lipid modifications and therapeutic effects mediated by hydroxydocosahexaenoic acid on Alzheimer's disease Biochim. Biophys. Acta 2014 1838 1680 1692
172. M.A. Fiol-deRoque, R. Gutierrez-Lanza, S. Teres, M. Torres, P. Barcelo, R.V. Rial, and et al. Cognitive recovery and restoration of cell proliferation in the dentate gyrus in the 5XFAD transgenic mice model of Alzheimer's disease following 2-hydroxy-DHA treatment Biogerontology 14 2013 763 775
173. R.M. Nisbet, J.C. Polanco, L.M. Ittner, and J. Gotz Tau aggregation and its interplay with amyloid-beta Acta Neuropathol. 129 2015 207 220
174. Q.L. Ma, F. Yang, E.R. Rosario, O.J. Ubeda, W. Beech, D.J. Gant, and et al. Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin J. Neurosci. 29 2009 9078 9089
175. B. De Strooper, P. Saftig, K. Craessaerts, H. Vanderstichele, G. Guhde, W. Annaert, and et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein Nature 391 1998 387 390
176. K.N. Green, H. Martinez-Coria, H. Khashwji, E.B. Hall, K.A. Yurko-Mauro, L. Ellis, and et al. Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels J. Neurosci. 27 2007 4385 4395
177. M. Igarashi, K. Ma, F. Gao, H.W. Kim, S.I. Rapoport, and J.S. Rao Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex J. Alzheimers Dis. 24 2011 507 517
178. D. Yuki, Y. Sugiura, N. Zaima, H. Akatsu, S. Takei, I. Yao, and et al. DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer's disease Sci. Rep. 4 2014 7130
179. W.L. Chung, J.J. Chen, and H.M. Su Fish oil supplementation of control and (n - 3) fatty acid-deficient male rats enhances reference and working memory performance and increases brain regional docosahexaenoic acid levels J. Nutr. 138 2008 1165 1171
180. S. Garcia-Calatayud, C. Redondo, E. Martin, J.I. Ruiz, M. Garcia-Fuentes, and P. Sanjurjo Brain docosahexaenoic acid status and learning in young rats submitted to dietary long-chain polyunsaturated fatty acid deficiency and supplementation limited to lactation Pediatr. Res. 57 2005 719 723
181. M. Hashimoto, T. Inoue, M. Katakura, Y. Tanabe, S. Hossain, S. Tsuchikura, and et al. Prescription n - 3 fatty acids, but not eicosapentaenoic acid alone, improve reference memory-related learning ability by increasing brain-derived neurotrophic factor levels in SHR.Cg-Lepr(cp)/NDmcr rats, a metabolic syndrome model Neurochem. Res. 38 2013 2124 2135
182. J.C. Delpech, C. Madore, C. Joffre, A. Aubert, J.X. Kang, A. Nadjar, and et al. Transgenic increase in n - 3/n - 6 fatty acid ratio protects against cognitive deficits induced by an immune challenge through decrease of neuroinflammation Neuropsychopharmacology 40 2015 525 536
183. M. Lebbadi, C. Julien, A. Phivilay, C. Tremblay, V. Emond, J.X. Kang, and et al. Endogenous conversion of omega-6 into omega-3 fatty acids improves neuropathology in an animal model of Alzheimer's disease J. Alzheimers Dis. 27 2011 853 869
184. Q. Meng, D.W. Luchtman, B. El Bahh, J.A. Zidichouski, J. Yang, and C. Song Ethyl-eicosapentaenoate modulates changes in neurochemistry and brain lipids induced by parkinsonian neurotoxin 1-methyl-4-phenylpyridinium in mouse brain slices Eur. J. Pharmacol. 649 2010 127 134
185. J. Monteiro, F.J. Li, M. Maclennan, A. Rabalski, M.H. Moghadasian, M.T. Nakamura, and et al. Menhaden oil, but not safflower or soybean oil, aids in restoring the polyunsaturated fatty acid profile in the novel delta-6-desaturase null mouse Lipids Health Dis. 11 2012 60
186. J. Monteiro, F. Askarian, M.T. Nakamura, M.H. Moghadasian, and D.W. Ma Oils rich in alpha-linolenic acid independently protect against characteristics of fatty liver disease in the Delta6-desaturase null mouse Can. J. Physiol. Pharmacol. 91 2013 469 479
187. C.A. Hoffmire, R.C. Block, K. Thevenet-Morrison, and E. van Wijngaarden Associations between omega-3 poly-unsaturated fatty acids from fish consumption and severity of depressive symptoms: an analysis of the 2005-2008 National Health and Nutrition Examination Survey Prostaglandins Leukot. Essent. Fat. Acids 86 2012 155 160
188. M.A. Beydoun, M.T.F. Kuczmarski, H.A. Beydoun, J.R. Hibbeln, M.K. Evans, and A.B. Zonderman Ω-3 fatty acid intakes are inversely related to elevated depressive symptoms among United States women J. Nutr. 143 2013 1743 1752
189. C. Chrysohoou, G. Tsitsinakis, G. Siassos, T. Psaltopoulou, N. Galiatsatos, V. Metaxa, G. Lazaros, A. Miliou, E. Giakoumi, C. Mylonakis, M. Zaromytidou, E. Economou, G. Triantafyllou, C. Pitsavos, and C. Stefanadis Fish consumption moderates depressive symptomatology in elderly men and women from the IKARIA study Cardiol. Res. Pract. 2011 2011 219578
190. A.C. Tsai, M. Lucas, O.I. Okereke, E.J. O'Reilly, F. Mirzaei, I. Kawachi, A. Ascherio, and W.C. Willett Suicide mortality in relation to dietary intake of n - 3 and n - 6 polyunsaturated fatty acids and fish: equivocal findings from 3 large US cohort studies Am. J. Epidemiol. 179 2014 1458 1466
191. W.H. Oddy, S. Hickling, M.A. Smith, T.A. O'Sullivan, M. Robinson, N.H. de Klerk, L.J. Beilin, T.A. Mori, J. Syrette, S.R. Zubrick, and S.R. Silburn Dietary intake of omega-3 fatty acids and risk of depressive symptoms in adolescents Depress. Anxiety 28 2011 582 588
192. M. Hennebelle, M. Plourde, R. Chouinard-Watkins, C.A. Castellano, P. Barberger-Gateau, and S.C. Cunnane Ageing and apoE change DHA homeostasis: relevance to age-related cognitive decline Proc. Nutr. Soc. 73 2014 80 86